SCHEMBL4418672

SCHEMBL4418672

CC(C)(C)OC(=O)N(CCNS(=O)(=O)c1nnc(-c2ccc(Cl)cc2)s1)CC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.37
PPARA Q07869 4/20 0.37
KDM1A O60341 1/20 0.35
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
LMNA P02545 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
POLB P06746 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MAPT P10636 3/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4413549 0.81 CA1 (0.33) POLB
SCHEMBL3139946 0.79 PPARA (0.39) PPARAHDAC6
SCHEMBL28757634 0.79 ALDH1A1 (0.35) PPARGPPARAKDM1AS1PR1MEN1
SCHEMBL3140234 0.75 PAX8 (0.42) LMNAHTTMAPTTSHR
SCHEMBL3133683 0.74 POLB (0.38) LMNAPOLBMAPT
SCHEMBL4418634 0.74 HTT (0.42) KDM1ALMNAMEN1KMT2AALOX12
SCHEMBL4412533 0.74 POLB (0.31) PPARGPPARALMNAPOLBNPSR1
SCHEMBL3814168 0.72 MAPT (0.40) LMNAHTTPOLBMAPTNPSR1
SCHEMBL31407633 0.71 GAA (0.40) PPARGPPARAMEN1KMT2AHDAC1
SCHEMBL3817156 0.69 MEN1 (0.44) LMNAMEN1KMT2AMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651642-B1 PNA MONOMER AND PRECURSOR PANAGENE INC (KR) 2009-11-04 EP disclosed
US-7211668-B2 PNA monomer and precursor PANAGENE, INC. (KR) 2007-05-01 US disclosed
EP-1651642-A4 PNA MONOMER AND PRECURSOR PANAGENE INC (KR) 2006-11-29 EP disclosed
EP-1651642-A1 PNA MONOMER AND PRECURSOR Panagene Inc. (KR) 2006-05-03 EP disclosed
US-20050026930-A1 PNA monomer and precursor PANAGENE, INC. (KR) 2005-02-03 US disclosed
WO-2005009998-A1 PNA MONOMER AND PRECURSOR PANAGENE INC. (US) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026930-A1 PNA monomer and precursor RNGTT, POLL, NSUN3 PPARG 3005/4885PPARA 2586/4885KDM1A 4839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.